Dose normalization [Study Per­for­mance]

posted by Relaxation  – Germany, 2021-05-27 17:29 (855 d 12:20 ago) – Posting: # 22373
Views: 1,534

❝ will not receive the actual dose, but will receive a smaller dose when assessing BD / BE (2x2x2) design)?


Hello yura.

I am sorry, but I am a little bit in a hurry and just wanted to start the answers here with one single comment.
As you are in a cross-over situation and assuming that the dose (BSA) of a subject will not change between periods, there is no need for a dose-adjustment with regard to the treatment comparison. Or the other way around: as you compare intraindividually the dose-adjustment would cancel out anyway.

Best regards!

Complete thread:

UA Flag
Activity
 Admin contact
22,763 posts in 4,775 threads, 1,627 registered users;
17 visitors (0 registered, 17 guests [including 11 identified bots]).
Forum time: 05:50 CEST (Europe/Vienna)

We should not speak so that it is possible
for the audience to understand us,
but so that it is impossible
for them to misunderstand us.    Quintilian

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5